Medicis wins bid to acquire Graceway assets

Dermatology company Medicis Pharmaceutical Corp. (NYSE:MRX) said it will acquire substantially all U.S. and Canadian assets and IP from Graceway Pharmaceuticals LLC (Bristol, Tenn.) for $455 million a...